1. Microbiology and Infectious Disease

Rapid bacterial evaluation beyond the colony forming unit in osteomyelitis

  1. Qi Sun
  2. Kimberley Huynh
  3. Dzenita Muratovic
  4. Nicholas J Gunn
  5. Anja R Zelmer
  6. Lucian Bogdan Solomon
  7. Gerald J Atkins  Is a corresponding author
  8. Dongqing Yang  Is a corresponding author
  1. Centre for Orthopaedic & Trauma Research, Faculty of Health and Medical Sciences, University of Adelaide, Australia
  2. Department of Orthopaedics and Trauma, Royal Adelaide Hospital, Australia
https://doi.org/10.7554/eLife.93698.3
Share this article
Cite this article
  1. Qi Sun
  2. Kimberley Huynh
  3. Dzenita Muratovic
  4. Nicholas J Gunn
  5. Anja R Zelmer
  6. Lucian Bogdan Solomon
  7. Gerald J Atkins
  8. Dongqing Yang
(2024)
Rapid bacterial evaluation beyond the colony forming unit in osteomyelitis
eLife 13:RP93698.
https://doi.org/10.7554/eLife.93698.3
  2. Download BibTeX
  3. Download .RIS

eLife assessment

This fundamental study addresses discrepancies in determining bacterial burden in osteomyelitis as determined by culture and enumeration using DNA. The authors present compelling data demonstrating the emergence of discrepancies between CFU counts and genome copy numbers detected by PCR in Staphylococcus aureus strains infecting osteocyte-like cells. The observations represent a substantial addition to the field of musculoskeletal infection, with possible broad applicability and clinical benefit to other infectious diseases.

https://doi.org/10.7554/eLife.93698.3.sa0

Abstract

Examination of bacteria/host cell interactions is important for understanding the aetiology of many infectious diseases. The colony forming unit (CFU) has been the standard for quantifying bacterial burden for the past century, however, this suffers from low sensitivity and is dependent on bacterial culturability in vitro. Our data demonstrate the discrepancy between the CFU and bacterial genome copy number in an osteomyelitis-relevant co-culture system and we confirm diagnosis and quantify bacterial load in clinical bone specimens. This study provides an improved workflow for the quantification of bacterial burden in such cases.

Introduction

Co-culturing mammalian host cells with bacteria in vitro is an important tool for examining the host–pathogen interaction in infectious disease modelling (Hofstee et al., 2020). One of the essential readouts is the intracellular bacterial burden carried by the infected host cells. The most commonly used method for enumerating such bacterial load is counting the colony forming unit (CFU) number by agar plate culturing following the lysis of host cells and release of bacteria (Staley and Konopka, 1985). However, the reliability of such measurements has long been recognised to be impacted by various factors, including, but not limited to, host cell/tissue type, bacterial strain, bacterial load, and culturing conditions for CFU enumeration (Chang et al., 1995; Davis et al., 2005). Osteomyelitis (OM), an infectious disease with pathogen-mediated infection of bone tissues, features a considerable proportion of infected but culture-negative cases, ranging between 20% and 40% (Bejon et al., 2010; Yoon et al., 2017; Kim et al., 2015). This clear deficiency in CFU evaluation creates difficulties for the accurate diagnosis and therefore treatment of OM.

Results and discussion

Staphylococci, including coagulase-negative species, such as S. epidermidis and S. aureus, comprise the major pathogens in adult OM (Kavanagh et al., 2018). In this study, we employed a previously established osteocyte-like cell model, differentiated SaOS2 (SaOS2-OY) and the single most common causative pathogen in OM, S. aureus, to simulate the in vitro infection of osteocytes, the most abundant cell type in bone tissue (Prideaux et al., 2014; Gunn et al., 2021). Two previously characterised S. aureus strains, a high virulence (methicillin-resistant S. aureus; MRSA) strain, WCH-SK2 (SK2), shown previously to establish an intracellular infection in human osteocytes (Yang et al., 2018) and a low virulence (methicillin-sensitive S. aureus; MSSA) strain, WCH-SK3 (SK3) (Bui and Kidd, 2015), were chosen for experimentation. In addition to CFU enumeration to quantify bacterial number, a polymerase chain reaction (PCR) approach measuring genomic DNA copies represented by a single-copy gene within the S. aureus genome, was also performed in parallel. In the past, real-time quantitative PCR (qPCR) assays have been widely used for the quantification of bacteria. However, the working principle of standard qPCR is dependent on the establishment of a standard curve using a known number of bacterial gene copies and the fitting of test samples into a linear regression to estimate the bacterial number for each assay (Kralik and Ricchi, 2017; Smith and Osborn, 2009). Here, we utilised digital droplet PCR (ddPCR) for this measurement. By its nature, the latter technique offers the advantage of counting the absolute target sequence copy number within the sample and removes the need for normalisation (Hindson et al., 2013). For all PCR-based assays, the quality of DNA containing the target sequence for amplification and quantification is critical for the sensitivity and reproducibility of readout. Therefore, methods for DNA preparation from both human and bacterial cells were examined. Here, we introduced the usage of DirectPCR Lysis Reagent (Direct buffer), a lysis buffer that maximises the release of genomic DNA from samples and is compatible with the downstream PCR analysis from cell culture lysate without any purification step. With the application of Direct buffer for DNA preparations in comparison to a commonly used DNA extraction spin column kit (DNA kit), the absolute bacterial genome copy number quantified by ddPCR was measured to be 5-fold higher in SaOS2-OY samples and 100-fold higher in samples from two strains of S. aureus, SK2 and SK3; better overall reproducibility among biological replicates was also achieved using Direct buffer over the standard approach (Figure 1A–C). Serial 10-fold dilutions of bacterial log-phase suspension cultures were used to generate DNA lysates for testing the extent of DNA release. Plotting genome copy number against CFU from the same cultures showed near perfect linear regression relationships (Figure 1D, E), confirming the complete and highly reproducible release of bacterial DNA. With this validating readout, we sought to determine if the elimination of purification steps by using the Direct buffer might minimise the sample loss associated with the utilisation of conventional column-based extraction methods (Schmitz et al., 2021). Furthermore, the release of genomic material by this reagent appeared to be complete and unbiased in our experiments, which led to higher consistency of inter- and intra-assays.

Figure 1
Download asset Open asset
Validation of DNA preparations from SaOS2-OY cells and S. aureus.

Digital droplet PCR (ddPCR) genome counting of SaOS2-OY (A), SK2 (B), and SK3 (C), comparing the Direct buffer approach ( ) and a standard DNA kit ( ) (four biological replicates with mean and standard errors were shown on graphs, ***p < 0.001 and ****p < 0.0001); demonstration of complete bacterial chromatin release from SK2 (D) and SK3 (E): correlation with CFU plating. Each data point represented the comparison of one colony-forming unit (CFU) recovery and one total DNA measurement; three independent experiments were carried out for each strain and similar results were achieved; representative results of one experiment are presented.

Using the combined approach of direct lysis DNA preparation and ddPCR quantification, we then examined S. aureus persistence in the intracellular environment in infected SaOS2-OY cells. Following infection, the SaOS2-OY and S. aureus co-cultures were lysed to break down host cell structures for the release of intracellular S. aureus for CFU development on agar plates. Consistent with previous findings, significant reductions ranging between 103- and 106-fold in cultured CFU on agar plates over the 5-day co-culture time period were observed in both SK2- and SK3-infected SaOS2-OY groups (Figure 2A–F). This trend was also found with low multiplicities of infection (MOI) (~107 total CFU/well, Figure 2C, E) and high MOI (~108 total CFU/well, Figure 2D, F) for initial bacteria-inoculated groups with either strain. However, when total DNA preparations from the whole culture lysates were taken for ddPCR quantification of bacterial genome copy number, differences in the dynamic changes of bacterial load were found. In the high virulence strain SK2-infected group, the genome copy numbers by 5-day post-infection were maintained at the levels of 107 and 108 cells/well for the low and high MOI groups, respectively (Figure 2C, D), similar to the original input levels.

Figure 2
Download asset Open asset
Measurement of intracellular S. aureus in SaOS2-OY cells in vitro.

Colony-forming unit (CFU) recovery of SK2 (A) and SK3 (B) from host SaOS2-OY cells, with haemolysis reactions ( ) and numerous small colony variants ( ) shown in SK2 group; quantification of SK2 and SK3 using CFU count (, left Y) and digital droplet PCR (ddPCR) count (⬤, right Y) from low (C, E) and high (D, F) multiplicities of infection (MOI) groups; relative human genome copy (%) with CTRL (⬤) vs. INF (◼) quantified by ddPCR from low (G) and high (H) MOI groups (four biological replicates with mean and standard errors are sḩown; **p < 0.01, ***p < 0.001, ****p < 0.0001; ns = not significant).

However, the low virulence strain SK3-infected group demonstrated a decrease in genome copy counts. Interestingly, regardless of the initial input amount, by 5-days post-infection, the remaining SK3 genome counts dropped to approximately 106 cells/well for both groups (Figure 2E, F). The quantification of human genome copy number was also performed in all groups to estimate the remaining host cells in culture and this also served as an indicator of host cell viability. With the low MOI co-cultures, the human genome copy counts in the presence of either strain of S. aureus were not statistically different from uninfected controls, across 1- and 5-days post-infection. When the initial bacterial inoculum was increased 10-fold to 108 cells/well, reductions in the human genome copies of ~30% and 50% were measured in 1- and 5-day post-infection groups, respectively; such a trend was found to be similar in both SK2- and SK3-infected groups. Overall, our observations demonstrated profound differences in the readout of the presence of intracellular bacteria when using CFU and ddPCR quantification methods. Such inconsistency between these readouts in our model was as high as 106-fold, with interaction of factors including initial bacterial load and strain variation. In contrast, comparison of the same quantification methods performed on bacterial suspension cultures yielded differences under twofold, indicated by the respective slope factor (less than 2) in the linear regression curves for both SK2 and SK3 strains (see Figure 1D, E). Together, our results indicate the dramatic change in bacterial culturability when comparing growth in ideal microbial suspension culture conditions and the growth-limiting intracellular environment. Therefore, we propose that the interaction between the host cell response to infection and pathogen adaptation to the intracellular environment will compromise the reliability of the standard CFU counting method alone for the evaluation of bacterial persistence in a bacteria/host cell co-culture experiment. However, phenotypic variations were also observed in the recovered colonies from agar plating, with variations in haemolytic activity and small colony variant (SCV) formation, particularly in the SK2 group (Figure 2A). SCV variants of S. aureus feature reduced metabolic activity and growth but are an indication of adaptation and the establishment of a chronic infection. This is consistent with the findings of reductions in CFU recovery but maintained levels of detectable genome copies, at least in the SK2-infected group.

To examine the applicability of this workflow to a clinical setting, we next extended the tests to clinical human bone specimens. Three clinically culture-negative periprosthetic joint infection (PJI) cases were chosen for analysis. All three cases were confirmed infected by clinical observation for typical PJI symptoms by clinicians, using the current gold-standard Musculoskeletal Infection Society (MSIS) criteria (Parvizi et al., 2018); while each patient presented with a sinus tract communicating with their prosthesis, a major diagnostic criterion, neither the culturing of the synovial membrane biopsies nor synovial fluid around the prosthesis returned any positive cultures from a clinical laboratory. The bone tissue sections from the three patients were examined by Masson’s trichrome staining in comparison to tissue section from an osteoarthritis (OA) patient as a non-infection control, to examine bone matrix degradation, according to our previous study (Ormsby et al., 2021). With this method, the red colour indicates intact bone matrix collagen and the blue colour corresponds to degraded collagen. Within all the histological observations, matrix degradation was found in sections of all three PJI patients (Figure 3B–D), whereas the staining of the control OA patient bone indicated intact collagen (Figure 3A), consistent with infection in the three PJI patient specimens (Ormsby et al., 2021). In addition to the gold-standard diagnostic approach and histological staining, we performed CFU analysis using homogenised bone tissue, and negative culture results were also recorded. In this study, the samples containing total genomic DNA were prepared from histological sections in conjunction with the use of the DirectPCR Lysis reagent. The prepared DNA samples were subjected to PCR amplification using a primer set targeting a highly conserved bacterial genomic region, elongation factor Tu (tuf) (Li et al., 2012), for the enrichment of bacterial signal within host/pathogen genomic mixture. The generated amplicons were then sequenced using an Oxford Nanopore Technology (ONT) MinION sequencer for the identification of bacterial species. All three patient bone DNA samples were confirmed to be bacterial genome-positive, with combinations identified of the coagulase-negative staphylococcal species S. haemolyticus, S. hominis, and S. epidermidis (Figure 3E–G). The respective total bacterial load for each of the samples was then quantified by ddPCR. Each bone sample examined contained between 2 × 104 and 1 × 106 bacterial genomic copies per million human genomic copies (Figure 3E–G). To confirm that the detected bacteria species were not introduced during the handling procedures, bone specimens from five primary total hip replacement (non-infected) patients were processed at the same time along with the PJI specimens; PCR reactions with negative tuf amplification for these bone samples indicated that operational contamination was unlikely (Figure 3—figure supplement 1).

Figure 3 with 2 supplements see all
Download asset Open asset
Pathogen diagnosis in clinical PJI bone specimens.

Masson’s trichrome staining of bone tissue sections of an osteoarthritis (OA) subject (A) and culture-negative periprosthetic joint infection (PJI) subjects I–III (B–D). Pathogen profiling using total DNA of bone specimens from the above three PJI patients (E–G) by ONT sequencing for the readout of pathogen species and digital droplet PCR (ddPCR) to quantify bacterial load as a ratio of bacterial: human genomic copies (error bars shown are the combination of the standard error of the mean from two individual DNA preparations and the device generated error from each of the ddPCR runs, with over 15,000 droplets read per sample).

In this study, by the analysis of genomic material, we have addressed the ineffectiveness of the classical bacterial CFU development approach in determining and quantifying a confirmed infection by both an in vitro experimental model and by examining human clinical cases. With the introduction of a direct DNA release approach, less handling is required while delivering increased accuracy. The addition of ddPCR provided the advantage of achieving absolute quantification without the need for a PCR standard curve, which is both cost and time effective. For the purposes of unknown pathogen diagnosis in clinical cases, the exact bacterial species readout is required from sequencing the generated amplicons. Here, the utilisation of ONT dramatically lowered the equipment and skill demands for performing this analysis, since the MinION sequencer is a portable device and the sequencing results are analysed by the on-board software with little bioinformatics requirement. Noted here, the usual whole-genome sequencing approach might not be suitable for this application, as in many of the clinical specimens, the amount of human genome can be orders of magnitude higher than the level of bacterial genomic material. Sequencing and analysing the relatively rare bacterial DNA present in this scenario is considerably more lengthy and costly. Therefore, a PCR approach was chosen to amplify the bacterial signal for detection. In this study, the bacterial gene tuf was chosen as the target sequence to generate PCR amplicons instead of the commonly used 16S rRNA gene sequence because of its greater discriminatory power (Hwang et al., 2011). Here, we took tuf sequences from S. aureus and the three coagulase-negative staphylococcal species identified in the clinical specimens for cross-comparisons (Figure 3—figure supplement 2A). Within the designated amplified sequence of only 271 bp, 11–22 (or 4.1–8.1% differences) mismatches were identified between these four species (Figure 3—figure supplement 2B). For achieving equivalent differences in 16S sequences among the four strains, PCR amplicons with over 1000 bp in length are required (data not shown). Again, the strategy of analysing a short amplicon not only offers reduced reaction time, more importantly, it minimises the chance of generating non-specific products by shortening the elongation step. The listed primer set targeting the tuf gene was confirmed to cover most of the species in genus Staphylococcus in silico. In practice, it is challenging to find universal primers that cover the entire bacterial domain. Hence, for future real-world tests in clinical diagnosis, the strategy of using multiple primer sets to cover common PJI pathogens might need to be considered. Together, this workflow is potentially applicable as a point-of-care diagnostic method with the prospect of a rapid turnover: within hours compared to the current procedure in the magnitude of days.

To conclude, for the purpose of quantifying the intracellular bacterial load in a host–pathogen co-culture setting, we have developed a workflow with the advantages of: (1) being rapid and labour-saving, with the elimination all DNA extraction steps by virtue of using the direct lysis approach; (2) minimisation of potential sample loss encountered with conventional DNA isolation methods, enabling better accuracy and reproducibility; (3) absolute genome copy number quantification by ddPCR for achieving superior consistency of intra-assay experiments; absolute bacterial load readout is particularly useful to track infection status with longitudinal serial samples from PJI patients; (4) sequencing analysis using the ONT MinION platform has the potential to become a point-of-care diagnostic approach when performing unknown pathogen identification in a clinical setting. Nevertheless, we suggest that the CFU plating method should not be omitted as it allows the evaluation of bacterial phenotypic adaptation in such experimentation.

Materials and methods

SaOS2 cell culture and differentiation

Request a detailed protocol

The human osteosarcoma cell line SaOS2 differentiated to an osteocyte-like stage was employed for performing bacteria/host co-cultures, as previously described (Gunn et al., 2021). Cells were seeded at a density of 2 × 104 cells/well in 48-well plates and cultured at 37°C/5% CO2, in growth media consisting of alpha modification of minimum essential medium (αMEM) (Thermo Fisher, Victoria, Australia) supplemented with 10% vol/vol foetal calf serum (FCS) (Thermo Fisher), 2 mM L-glutamine (Thermo Fisher), and 1 U/ml penicillin/streptomycin (Thermo Fisher). At 90% confluence, SaOS2 cultures were switched to osteogenic differentiation medium comprising αMEM supplemented with 5% vol/vol FCS, 100 mM ascorbate 2-phosphate (Sigma-Aldrich, St Louis, USA), 1.8 mM potassium di-hydrogen phosphate (Sigma-Aldrich), 1 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (Thermo Fisher), 2 mM L-glutamine, and 1 U/ml penicillin/streptomycin. Cells were then maintained under differentiation conditions for 28 days to achieve an osteocyte-like phenotype (SaOS2-OY) (Prideaux et al., 2014).

S. aureus preparation

Request a detailed protocol

Two pre-characterised S. aureus strains, an MRSA strain, WCH-SK2 (SK2) (Bui and Kidd, 2015) and an MSSA strain, WCH-SK3 (SK3), were grown in Terrific Broth (Thermo Fisher) on a 37°C/200 rpm rocking platform to achieve log-phase suspension cultures individually. Bacteria were pelleted by 3000 × g for 5 min centrifugation and then resuspended in sterile phosphate-buffered saline (PBS) to estimate cell number by the optical density at 600 nm light absorption. The two bacteria suspensions were then taken to undergo 10-fold serial dilutions and the diluents were individually plated on blood agar containing 10% vol/vol defibrinated sheep blood (Thermo Fisher) to determine the CFU number from the original bacterial suspension preparations. The calculated CFU numbers from agar plates were compared to the ddPCR-quantified genome copy numbers.

Host cell infection by co-culturing of SaOS2-OY and S. aureus

Request a detailed protocol

For host cell infection, bacterial suspension cultures were resuspended in sterile PBS, as described above, to achieve the density for low and high MOI. The differentiation media for SaOS2-OY was removed and the cells washed twice with PBS. The resulting bacterial inoculums were added to SaOS2-OY cells to allow invasion for 1 hr at 37°C/5% CO2. Post-infection, cultures were washed twice with PBS and incubated at 37°C/5% CO2 with 20 µg/ml lysostaphin (Sigma-Aldrich) in antibiotic-free media for 24 hr to eliminate extracellular bacteria before replenishment with fresh differentiation medium. Supernatants were streaked on agar plates to verify the absence of extracellular bacteria at 24- and 120-hr post-infection.

Measurements of intracellular bacterial number by CFU counting

Request a detailed protocol

The intracellular bacteria numbers were determined at 24- and 120-hr post-infection time points by spreading serial dilutions of cell lysates on blood agar and culturing at 37°C/5% CO2 for 48 hr.

DNA extraction from host cells and bacteria

Request a detailed protocol

For genomic quantification, total DNA was isolated using either DNeasy Blood & Tissue Kits (Qiagen Inc, VIC, Australia) or DirectPCR Lysis Reagent (Direct buffer) (Viagen Biotech Inc, CA, USA), as per the manufacturer’s instructions. For the new approach of using the Direct buffer, 500 μl buffer together with 200 μg/ml proteinase K (Thermo Fisher) was used for the lysis of one SaOS2-OY sample in one well from a 48-well tissue culture plate or one pelleted bacterial sample prepared from serial dilutions of a suspension culture. Individual cell lysates were transferred to 1.5 ml reaction tubes, digested at 55°C for 35 min and then heat-inactivated at 85°C for 15 min to terminate enzymic digestion. The processed lysates were then ready for PCR analyses.

Digital droplet polymerase chain reaction

Request a detailed protocol

The ddPCR assay was performed using QX200 Digital Droplet PCR System (Bio-Rad Laboratories, USA), as per the manufacturer’s instructions. Primer sets targeting a human genome-specific sequence within the single-copy type X collagen (COL10A1) gene and a S. aureus genome-specific sequence within the sigma factor B (sigB) gene were used. The sequences of primer sets were:

  • COL10A1: forward 5′-ccaccaggtcaagcagtcat-3′, reverse 5′-gttggcactaacaagaggggt-3′

  • sigB: forward 5′-ggggcaacaagatgaccatt-3′, reverse 5′-tgccgttctctgaagtcgtg-3′

Analysis of human bone tissues

Request a detailed protocol

All human studies received institutional research ethics approval (Royal Adelaide Hospital Human Research Ethics Committee Approval No. 14446). Bone biopsies were collected from patients undergoing either primary total hip replacement or revision total hip replacement surgery for PJI, with informed, written patient consent. Each bone specimen was separated into two parts. One of these was homogenised in a bead-beating tissue homogeniser (Bead Ruptor Elite, Omni International, Kennesaw, GA, USA), with two cycles of beating at 3 m/s for 30 s to disassociate the bone structure for the release of potentially viable bacteria. Bone homogenates were then sent to a clinical pathology laboratory (SA Pathology, Adelaide, Australia) for CFU analysis. Clinical soft tissue and fluid samples were sent to SA Pathology directly from surgery for pathogen analysis. The second piece of bone biopsy was processed and de-mineralised using OSTEOSOFT (Sigma-Aldrich) solution for standard paraffin embedding procedure. Post-embedding, the bone tissues were sectioned under DNase/RNase-free conditions. One 5 μm section from each bone specimen was used for Masson’s Trichrome staining, as described in our previous study (Ormsby et al., 2021), and six sections were pooled together in DirectPCR Lysis Reagent for the isolation of total genomic DNA, as described above. Prepared DNA samples were then subjected to (1) conventional PCR amplification for an ONT sequencing readout (MinION sequencer, Oxford Nanopore Technology, Oxford, UK), according to the manufacturer’s instructions; (2) ddPCR for the absolute quantification for both human and bacterial genome copy number. The primer sets targeting the human COL10A1 genomic sequence, as listed above, and bacterial tuf sequence primers (forward 5′-ttctcaatcactggtcgtgg-3′, reverse 5′-ggagtatgacgtccaccttc-3′) were used for measuring human and bacterial genome copies, respectively. The output sequencing data were analysed by Epi2ME software within the WIMP workflow (Oxford Nanopore Technologies) for bacterial taxonomical analysis.

Statistics

The results were graphed as means ± standard errors of the means. The significance between two treatment groups was evaluated using two-tailed T-test using GraphPad Prism 10.2 (GraphPad Software, MA, USA), where applicable.

Data availability

DNA sequencing data was uploaded to Dryad (https://doi.org/10.5061/dryad.s4mw6m9f5); all other data generated or analysed during this study are included in the manuscript and supporting files.

The following data sets were generated
    1. Yang D
    2. Sun Q
    3. Huynh K
    4. Muratovic D
    5. Gunn NJ
    6. Zelmer AR
    7. Solomon LB
    8. Atkins GJ
    (2024) Dryad Digital Repository
    Data from: Beyond the colony-forming-unit: Rapid bacterial evaluation in Osteomyelitis.
    https://doi.org/10.5061/dryad.s4mw6m9f5

References

Article and author information

Author details

  1. Qi Sun

    Centre for Orthopaedic & Trauma Research, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia
    Contribution
    Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review and editing
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4826-6724

  2. Kimberley Huynh

    Centre for Orthopaedic & Trauma Research, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia
    Contribution
    Data curation, Formal analysis, Investigation
    Competing interests
    No competing interests declared

  3. Dzenita Muratovic

    Centre for Orthopaedic & Trauma Research, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia
    Contribution
    Resources, Data curation, Formal analysis, Validation, Investigation, Methodology, Writing – review and editing
    Competing interests
    No competing interests declared

  4. Nicholas J Gunn

    Centre for Orthopaedic & Trauma Research, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia
    Contribution
    Validation, Investigation, Methodology
    Competing interests
    No competing interests declared

  5. Anja R Zelmer

    Centre for Orthopaedic & Trauma Research, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia
    Contribution
    Validation, Investigation
    Competing interests
    No competing interests declared

  6. Lucian Bogdan Solomon

    1. Centre for Orthopaedic & Trauma Research, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia
    2. Department of Orthopaedics and Trauma, Royal Adelaide Hospital, Adelaide, Australia
    Contribution
    Resources, Investigation, Methodology, Writing – review and editing
    Competing interests
    No competing interests declared

  7. Gerald J Atkins

    Centre for Orthopaedic & Trauma Research, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia
    Contribution
    Conceptualization, Resources, Supervision, Funding acquisition, Project administration, Writing – review and editing
    For correspondence
    gerald.atkins@adelaide.edu.au
    Competing interests
    No competing interests declared
    Additional information
    Co-senior authors
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3123-9861

  8. Dongqing Yang

    Centre for Orthopaedic & Trauma Research, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia
    Contribution
    Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing
    For correspondence
    dongqing.yang@adelaide.edu.au
    Competing interests
    No competing interests declared
    Additional information
    Co-senior authors
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5471-6288

Funding

National Health and Medical Research Council (2011042)

  • Gerald J Atkins
  • Dongqing Yang

Australian Orthopaedic Association

  • Lucian Bogdan Solomon
  • Gerald J Atkins

University of Adelaide (Postgraduate Research Scholarship)

  • Qi Sun

The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.

Acknowledgements

This work was supported by a National Health and Medical Research Council of Australia (NHMRC) Ideas Grant scheme (ID 2011042) awarded to GJA and DY and an Australian Orthopaedic Association Research Grant awarded to GJA and LBS. Oxford Nanopore sequencing was supported by a University of Adelaide Faculty of Health and Medical Sciences infrastructure grant with technical assistance provided by Ms Thessa Kroes and Dr. Mark Corbett. QS was supported by a University of Adelaide Faculty of Health and Medical Sciences Postgraduate Research Scholarship.

Ethics

All human studies received institutional research ethics approval (Royal Adelaide Hospital Human Research Ethics Committee Approval No. 14446). Bone biopsies were collected from patients undergoing either primary total hip replacement or revision total hip replacement surgery for PJI, with informed, written patient consent.

Version history

  1. Sent for peer review:
  2. Preprint posted:
  3. Reviewed Preprint version 1:
  4. Reviewed Preprint version 2:
  5. Version of Record published:

Cite all versions

You can cite all versions using the DOI https://doi.org/10.7554/eLife.93698. This DOI represents all versions, and will always resolve to the latest one.

Copyright

© 2024, Sun et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 649
    views
  • 62
    downloads
  • 2
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Qi Sun
  2. Kimberley Huynh
  3. Dzenita Muratovic
  4. Nicholas J Gunn
  5. Anja R Zelmer
  6. Lucian Bogdan Solomon
  7. Gerald J Atkins
  8. Dongqing Yang
(2024)
Rapid bacterial evaluation beyond the colony forming unit in osteomyelitis
eLife 13:RP93698.
https://doi.org/10.7554/eLife.93698.3

Share this article

https://doi.org/10.7554/eLife.93698

Categories and tags

Research organisms

Further reading

    1. Cell Biology
    2. Microbiology and Infectious Disease

    Zika virus remodels and hijacks IGF2BP2 ribonucleoprotein complex to promote viral replication organelle biogenesis

    Clément Mazeaud, Stefan Pfister ... Laurent Chatel-Chaix
    Research Article

    Zika virus (ZIKV) infection causes significant human disease that, with no approved treatment or vaccine, constitutes a major public health concern. Its life cycle entirely relies on the cytoplasmic fate of the viral RNA genome (vRNA) through a fine-tuned equilibrium between vRNA translation, replication, and packaging into new virions, all within virus-induced replication organelles (vROs). In this study, with an RNA interference (RNAi) mini-screening and subsequent functional characterization, we have identified insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) as a new host dependency factor that regulates vRNA synthesis. In infected cells, IGF2BP2 associates with viral NS5 polymerase and redistributes to the perinuclear viral replication compartment. Combined fluorescence in situ hybridization-based confocal imaging, in vitro binding assays, and immunoprecipitation coupled to RT-qPCR showed that IGF2BP2 directly interacts with ZIKV vRNA 3’ nontranslated region. Using ZIKV sub-genomic replicons and a replication-independent vRO induction system, we demonstrated that IGF2BP2 knockdown impairs de novo vRO biogenesis and, consistently, vRNA synthesis. Finally, the analysis of immunopurified IGF2BP2 complex using quantitative mass spectrometry and RT-qPCR revealed that ZIKV infection alters the protein and RNA interactomes of IGF2BP2. Altogether, our data support that ZIKV hijacks and remodels the IGF2BP2 ribonucleoprotein complex to regulate vRO biogenesis and vRNA neosynthesis.

    1. Genetics and Genomics
    2. Microbiology and Infectious Disease

    Genetic stability of Mycobacterium smegmatis under the stress of first-line antitubercular agents

    Dániel Molnár, Éva Viola Surányi ... Judit Toth
    Research Article

    The sustained success of Mycobacterium tuberculosis as a pathogen arises from its ability to persist within macrophages for extended periods and its limited responsiveness to antibiotics. Furthermore, the high incidence of resistance to the few available antituberculosis drugs is a significant concern, especially since the driving forces of the emergence of drug resistance are not clear. Drug-resistant strains of Mycobacterium tuberculosis can emerge through de novo mutations, however, mycobacterial mutation rates are low. To unravel the effects of antibiotic pressure on genome stability, we determined the genetic variability, phenotypic tolerance, DNA repair system activation, and dNTP pool upon treatment with current antibiotics using Mycobacterium smegmatis. Whole-genome sequencing revealed no significant increase in mutation rates after prolonged exposure to first-line antibiotics. However, the phenotypic fluctuation assay indicated rapid adaptation to antibiotics mediated by non-genetic factors. The upregulation of DNA repair genes, measured using qPCR, suggests that genomic integrity may be maintained through the activation of specific DNA repair pathways. Our results, indicating that antibiotic exposure does not result in de novo adaptive mutagenesis under laboratory conditions, do not lend support to the model suggesting antibiotic resistance development through drug pressure-induced microevolution.

    1. Microbiology and Infectious Disease

    Bacillus velezensis HBXN2020 alleviates Salmonella Typhimurium infection in mice by improving intestinal barrier integrity and reducing inflammation

    Linkang Wang, Haiyan Wang ... Ping Qian
    Research Article

    Bacillus velezensis is a species of Bacillus that has been widely investigated because of its broad-spectrum antimicrobial activity. However, most studies on B. velezensis have focused on the biocontrol of plant diseases, with few reports on antagonizing Salmonella Typhimurium infections. In this investigation, it was discovered that B. velezensis HBXN2020, which was isolated from healthy black pigs, possessed strong anti-stress and broad-spectrum antibacterial activity. Importantly, B. velezensis HBXN2020 did not cause any adverse side effects in mice when administered at various doses (1×107, 1×108, and 1×109 CFU) for 14 days. Supplementing B. velezensis HBXN2020 spores, either as a curative or preventive measure, dramatically reduced the levels of S. Typhimurium ATCC14028 in the mice’s feces, ileum, cecum, and colon, as well as the disease activity index (DAI), in a model of infection caused by this pathogen in mice. Additionally, supplementing B. velezensis HBXN2020 spores significantly regulated cytokine levels (Tnfa, Il1b, Il6, and Il10) and maintained the expression of tight junction proteins and mucin protein. Most importantly, adding B. velezensis HBXN2020 spores to the colonic microbiota improved its stability and increased the amount of beneficial bacteria (Lactobacillus and Akkermansia). All together, B. velezensis HBXN2020 can improve intestinal microbiota stability and barrier integrity and reduce inflammation to help treat infection by S. Typhimurium.